Xilio Therapeutics Inc
XLO - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$155.82M
Close$
$14.88
85.4% upside
Current Fair Value
85.4% upsideUndervalued by 85.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $155.82 Million |
|---|---|
| Enterprise Value | $48.69 Million |
| Earnings per Share | $-4.19 |
| Beta | -0.12 |
| Outstanding Shares | 19,404,688 |
Return
| Return on Equity | -7.67% |
|---|---|
| Return on Assets | -3.59% |
| Return on Invested Capital | -14.96% |
Valuation & Multiples
| P/E Ratio | -5.39 |
|---|---|
| PEG | 9.02 |
| Price to Sales | 2.68 |
| Price to Book Ratio | 2.68 |
| Enterprise Value to Revenue | -0.85 |
| Enterprise Value to EBIT | 3.02 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | -0.53 |
| Debt to Equity | 0.4 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.59
Consensus analyst estimateRevenue Estimate
$12.72 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.94
Consensus analyst estimateRevenue Estimate
$4.92 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 14.21%▲ 0.71% |
|---|---|
| Total Invested | $26.41M▲ 19.88% |
| Investors Holding | 26▲ 2.00% |